Science 37

By Jonah Comstock May 17, 2018
Sanofi’s approach to digital health is broad, but focused, Rachel Sha, the company’s vice president of digital business development and licensing, told MobiHealthNews in an interview ahead of the upcoming BIO 2018 conference in Boston, where Sha will be speaking on a range of digital health-related topics. “At Sanofi we’re lucky in the sense that we have a very clear set of digital priorities...
By Dave Muoio May 3, 2018
Garmin and the University of Kansas Medical Center are taking a closer look at the role wearables can play in detecting and managing medical conditions, the groups announced earlier this week. Initially focused on sleep apnea and atrial fibrillation, the collaboration is a clear step beyond the fitness and wellness realm to which Garmin’s wearables have so far been limited. “Garmin Health is...
By Dave Muoio April 24, 2018
Today, remote clinical trial company Science 37 and diagnostic clinical decision support system maker VisualDx have announced an effort to jointly engage patients and clinicians in their respective networks. The partnership will give VisualDx users access to Science 37’s clinical trial research platform, while those within Science 37’s network will be able to view VisualDx’s skin health medical...
By Laura Lovett March 9, 2018
Predictive analytics platform Clew Medical has recently announced its partnership with WakeMed for its clinical trials in the eICU to detect patient deterioration in realtime. Clew uses machine learning algorithms and customized physiological models to help clinicians make decisions with actionable clinical, operational and financial insights. The company’s AI system will give WakeMed access to...
By Jonah Comstock December 8, 2017
Otsuka Pharmaceuticals has deepened its relationship with Science 37, a startup it invested in earlier this year. Otsuka will use Science 37’s mobile clinical trial technology to further digitize its own trials, with an initial focus on psychiatry and behavioral health. “Otsuka is dedicated to promoting innovation in clinical trials as a means of expanding the diversity of patients enrolled in...
By Dave Muoio December 1, 2017
Editor's note: Since publication, some of this story's quotes have been edited for clarity. With billions of dollars and countless hours of human effort spent each year validating new drugs, devices, and medical interventions, it’s little surprise that the healthcare industry is turning to technology to streamline the process. From participant recruitment to data collection to adherence, clinical...
By Dave Muoio October 24, 2017
Los Angeles-based research company Science 37 announced the completion of a clinical study for AOBiome Therapeutics conducted entirely through a smartphone app. The Phase 2b study ran on the back of Science 37’s mobile Network Oriented Research Assistant (NORA) platform, which allows for real-time video chat, customized self-photography models, data collection, and electronic consent. Science 37...
By Heather Mack July 6, 2017
San Francisco-based Mendel.ai, a startup that is developing an artificial intelligence-powered platform to match people with cancer to clinical trials, has raised $2 million in seed funding from DCM Ventures, BootstrapLabs, Indie Bio, LaunchCapital and SOSV. Medel.ai will use the capital to forge partnerships with hospitals and cancer genomics companies to bring the system into use. For $99,...
By Jonah Comstock April 25, 2017
Remote clinical trial company Science 37 has raised $29 million in a round led by Glynn Capital Management with participation from Google's investment arm GV. One more new investor -- AmGen ventures -- contributed, as did existing investors Lux Capital, Redmile Group, dRx Capital, and Sanofi Ventures. It's a large round with impressive investors, but it is technically a down round from last fall'...
By Heather Mack October 18, 2016
Mobile clinical trials company Science 37, which connects willing individuals to researchers so they can participate in trials from their homes, has raised $31 million in Series B funding. Previously, the company raised $6.5 million. The round was led by Redmile Group, with participation from Lux Capital and Sanofi Genzyme BioVentures, the latter of which will also provide Science 37 with...

Editor's Pick